(Q45403934)

English

A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Toxoplasma gondii

0 references

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

Zhang G

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Huong VT

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Battur B

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Zhou J

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Zhang H

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Liao M

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Kawase O

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Lee EG

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Dautu G

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Igarashi M

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Nishikawa Y

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Xuan X

12

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

17 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

134

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Pt 10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1339-1346

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Characterization of pseudorabies virus glycoprotein gII expressed by recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Toxoplasma gondii: the model apicomplexan.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Toxoplasmosis - a waterborne zoonosis

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Toxoplasmosis: the first commercial vaccine

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Detection of antibodies to Hypoderma lineatum in cattle by Western blotting with recombinant hypodermin C antigen

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Effect of Prior Immunity on the Shedding of Virulent Revertant Virus in Feces after Oral Immunization with Live Attenuated Poliovirus Vaccines

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Expression of canine interferon-gamma by a recombinant vaccinia virus and its antiviral effect

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Progress in DNA-based heterologous prime-boost immunization strategies for malaria

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Immunization with DNA through the skin

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Establishment of gene-vaccinated skin grafting against Toxoplasma gondii infection in mice.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

21 January 2018

Toxoplasma gondii: difference of invasion into tissue of digestive organs between susceptible and resistant strain and influence of IFN-gamma in mice inoculated with the cysts perorally

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines

1 reference

https://api.crossref.org/works/10.1017%2FS0031182007002892

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0031182007002892

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45403934&oldid=2076639127"